Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A vs Steroids for Chronic Plantar Fasciitis
NCT02196155Recruiting
- Sponsor
- Insel Gruppe
- Start
- Jul 2016
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of botulinum toxin type A in plantar fasciitis (3 arms), sponsored by Insel Gruppe. Primary endpoint: Change from baseline in foot pain at 24 months. Started Jul 2016; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT02196155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196155.